Sinovial is a sterile intra-articular viscosupplement containing sodium hyaluronate, designed to restore the natural properties of synovial fluid in patients with degenerative joint disorders. Manufactured in Italy by IBSA, it is intended to improve joint lubrication, reduce pain, and support mobility.
Each prefilled syringe contains 32 mg of sodium hyaluronate in 2 ml (1.6%) and is supplied for single-use administration.
Sinovial is a high-purity sodium hyaluronate solution intended for intra-articular injection. It supplements the natural hyaluronic acid found in synovial fluid, helping restore its viscoelastic properties and supporting smoother joint movement.
It is commonly used in the management of osteoarthritis and other degenerative joint conditions.
Following injection into the affected joint, Sinovial helps:
Healthcare professionals may recommend Sinovial for:
Treatment should always be based on medical evaluation.
Sinovial must be administered only by a qualified healthcare professional experienced in intra-articular injections.
The treatment schedule depends on:
Self-injection is not recommended.
Some patients may experience temporary:
These reactions are generally short-lived.
Sinovial should not be used in patients with:
It is used for viscosupplementation to improve joint lubrication and reduce symptoms associated with osteoarthritis.
Each syringe contains 32 mg of highly purified sodium hyaluronate in 2 ml.
No. The injection should only be performed by a qualified healthcare professional.
Many patients notice gradual symptom improvement after treatment, although results vary between individuals.
It is commonly used for the knee but may also be suitable for other synovial joints based on clinical assessment.
Sinovial is classified as a medical device used for intra-articular viscosupplementation.
Ask a question or inquire about delivery to your country
